Olatz Crende

403 total citations
16 papers, 312 citations indexed

About

Olatz Crende is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Olatz Crende has authored 16 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in Olatz Crende's work include Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Olatz Crende is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Olatz Crende collaborates with scholars based in Spain, United States and Germany. Olatz Crende's co-authors include Fernando Vidal‐Vanaclocha, Elvira Olaso, Gaskon Ibarretxe, Scott L. Friedman, Fernando Unda, Iker Badiola, Teresa Carrascal, María Valcárcel, Beatriz Arteta and Aitor Benedicto and has published in prestigious journals such as Gut, International Journal of Molecular Sciences and American Journal Of Pathology.

In The Last Decade

Olatz Crende

16 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olatz Crende Spain 8 155 72 71 48 45 16 312
Pucha Jiang China 12 194 1.3× 54 0.8× 74 1.0× 24 0.5× 49 1.1× 24 351
Isabel Burghardt Switzerland 11 210 1.4× 127 1.8× 122 1.7× 25 0.5× 26 0.6× 16 453
Edo Israely United States 5 321 2.1× 70 1.0× 45 0.6× 20 0.4× 86 1.9× 8 538
Sweta Sudhir United States 8 134 0.9× 99 1.4× 64 0.9× 12 0.3× 58 1.3× 16 373
Victoria Zismanov Israel 14 384 2.5× 103 1.4× 70 1.0× 38 0.8× 64 1.4× 20 559
Molly R. Kelly‐Goss United States 11 172 1.1× 85 1.2× 46 0.6× 17 0.4× 56 1.2× 14 345
Angela Mahoney United States 5 256 1.7× 45 0.6× 45 0.6× 11 0.2× 31 0.7× 9 385
Yasunobu Nishiwaki Japan 5 241 1.6× 87 1.2× 81 1.1× 37 0.8× 81 1.8× 6 389
Shunli Ding France 5 192 1.2× 77 1.1× 56 0.8× 10 0.2× 63 1.4× 6 352
Gyöngyi Kudlik Hungary 12 170 1.1× 88 1.2× 110 1.5× 13 0.3× 41 0.9× 15 363

Countries citing papers authored by Olatz Crende

Since Specialization
Citations

This map shows the geographic impact of Olatz Crende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olatz Crende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olatz Crende more than expected).

Fields of papers citing papers by Olatz Crende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olatz Crende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olatz Crende. The network helps show where Olatz Crende may publish in the future.

Co-authorship network of co-authors of Olatz Crende

This figure shows the co-authorship network connecting the top 25 collaborators of Olatz Crende. A scholar is included among the top collaborators of Olatz Crende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olatz Crende. Olatz Crende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Crende, Olatz, Jesús Seco‐Calvo, Ainhoa Fernández‐Atutxa, et al.. (2024). The Non-Linear Profile of Aging: U-Shaped Expression of Myostatin, Follistatin and Intermediate Signals in a Longitudinal In Vitro Murine Cell Sarcopenia Model. Proteomes. 12(4). 34–34. 1 indexed citations
2.
Crende, Olatz, et al.. (2022). What Are the Roles of Proprotein Convertases in the Immune Escape of Tumors?. Biomedicines. 10(12). 3292–3292. 3 indexed citations
3.
Gerovska, Daniela, Patricia García-Gallastegui, Olatz Crende, et al.. (2021). GeromiRs Are Downregulated in the Tumor Microenvironment during Colon Cancer Colonization of the Liver in a Murine Metastasis Model. International Journal of Molecular Sciences. 22(9). 4819–4819. 7 indexed citations
4.
García-Gallastegui, Patricia, et al.. (2021). Minbiziaren aurkako CAR-T zelulen bidezko immunoterapia. EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria. 77–88. 1 indexed citations
5.
Gómez‐Santos, Laura, et al.. (2020). Identification of sugar moieties in chief cells of the rat fundic gastric glands. Anatomical Science International. 96(2). 221–230. 1 indexed citations
6.
Vidal‐Vanaclocha, Fernando, Olatz Crende, Alejandro Herreros‐Pomares, et al.. (2020). Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes. Seminars in Cancer Biology. 71. 122–133. 9 indexed citations
7.
Gerovska, Daniela, Patricia García-Gallastegui, Olatz Crende, et al.. (2020). Proprotein convertases blockage up-regulates specifically metallothioneins coding genes in human colon cancer stem cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(3). 118912–118912. 3 indexed citations
8.
Crende, Olatz, Patricia García-Gallastegui, Jon Luzuriaga, et al.. (2020). Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp. Biology. 9(12). 426–426. 6 indexed citations
9.
García-Gallastegui, Patricia, Gaskon Ibarretxe, Samuel Rivero-Hinojosa, et al.. (2019). Similarities and differences in tissue distribution of DLK1 and DLK2 during E16.5 mouse embryogenesis. Histochemistry and Cell Biology. 152(1). 47–60. 7 indexed citations
10.
Crende, Olatz, Marianna Sabatino, María Valcárcel, et al.. (2013). Metastatic Lesions with and without Interleukin-18–Dependent Genes in Advanced-Stage Melanoma Patients. American Journal Of Pathology. 183(1). 69–82. 11 indexed citations
11.
Valcárcel, María, Teresa Carrascal, Olatz Crende, & Fernando Vidal‐Vanaclocha. (2013). IL-18 Regulates Melanoma VLA-4 Integrin Activation through a Hierarchized Sequence of Inflammatory Factors. Journal of Investigative Dermatology. 134(2). 470–480. 25 indexed citations
12.
Ibarretxe, Gaskon, Olatz Crende, Iker Badiola, et al.. (2012). Epiprofin/Sp6 regulates Wnt-BMP signaling and the establishment of cellular junctions during the bell stage of tooth development. Cell and Tissue Research. 350(1). 95–107. 26 indexed citations
13.
Ibarretxe, Gaskon, et al.. (2012). Neural Crest Stem Cells from Dental Tissues: A New Hope for Dental and Neural Regeneration. Stem Cells International. 2012. 1–12. 92 indexed citations
14.
Olaso, Elvira, Beatriz Arteta, Aitor Benedicto, Olatz Crende, & Scott L. Friedman. (2011). Loss of Discoidin Domain Receptor 2 Promotes Hepatic Fibrosis after Chronic Carbon Tetrachloride through Altered Paracrine Interactions between Hepatic Stellate Cells and Liver-Associated Macrophages. American Journal Of Pathology. 179(6). 2894–2904. 42 indexed citations
15.
Valcárcel, María, Lorea Mendoza, Teresa Carrascal, et al.. (2011). Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. Journal of Translational Medicine. 9(1). 142–142. 18 indexed citations
16.
Badiola, Iker, Elvira Olaso, Olatz Crende, Scott L. Friedman, & Fernando Vidal‐Vanaclocha. (2011). Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut. 61(10). 1465–1472. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pucha Jiang Breakdown of academic impact, for papers by Isabel Burghardt Breakdown of academic impact, for papers by Edo Israely Breakdown of academic impact, for papers by Sweta Sudhir Breakdown of academic impact, for papers by Victoria Zismanov Breakdown of academic impact, for papers by Molly R. Kelly‐Goss Breakdown of academic impact, for papers by Angela Mahoney Breakdown of academic impact, for papers by Yasunobu Nishiwaki Breakdown of academic impact, for papers by Shunli Ding Breakdown of academic impact, for papers by Gyöngyi Kudlik
Rankless by CCL
2026